Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP Study

Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP Study

Risk-adapted prostate cancer (PC) screening is currently based on a combination of prostate-specific antigen (PSA) testing, risk assessment, and magnetic resonance imaging (MRI). Classical venous blood sampling is usually performed by health care professionals, which may reduce participation in futu...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin Wallisch, Peter Albers, Nikolaus Becker, Friedrich Boege, Derik Hermsen, Tanmay Ramesh Londhe, Jale Lakes, Jan Philipp Radtke, Agne Krilaviciute, Petra Seibold, Axel Benner, Maral Saadati, Stefan Holdenrieder, Rouvier Al-Monajjed
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:European Urology Open Science
Subjects:
Prostate cancer
Risk-adapted screening
Prostate-specific antigen
Capillary blood
Population-based screening
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168325001259
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items